✦ LIBER ✦

Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial

✍ Scribed by ERICH V. DE PAULA; KAAN KAVAKLI; JOHNNY MAHLANGU; YASMIN AYOB; STEVEN R. LENTZ; MASSIMO MORFINI; LÁSZLÓ NEMES; SILVA Z. ŠALEK; MIDORI SHIMA; JERZY WINDYGA; SILKE EHRENFORTH; AMPAIWAN CHUANSUMRIT; FOR THE 1804 (ADEPTTM1) INVESTIGATORS

Book ID: 109154955
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 231 KB
Volume: 10
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2011.04549.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, prospective clinical trial o

Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors

✍ B. A. KONKLE; L. S. EBBESEN; E. ERHARDTSEN; R. P. BIANCO; T. LISSITCHKOV; L. RUS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 674 KB

Pseudoprolongation of the Prothrombin Ti

Pseudoprolongation of the Prothrombin Time During Treatment with Recombinant Factor VIIa for Bleeding in a Patient with a Spontaneous Factor VIII Inhibitor

✍ Marcus E. Carr; Jan G. Kuhn; Erika J. Martin; Ann R. Tidwell; Maura K. Hagane 📂 Article 📅 2003 🏛 Carden Jennings Publishing 🌐 English ⚖ 70 KB

A prospective randomized trial of high a

A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors

✍ E. SANTAGOSTINO; M. E. MANCUSO; A. ROCINO; G. MANCUSO; F. SCARAGGI; P. M. MANNUC 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Successful use of recombinant factor VII

Successful use of recombinant factor VIIa for emergency fasciotomy in a patient with hemophilia A and high-titer inhibitor unresponsive to factor VIII inhibitor bypassing activity

✍ Raymond G. Watts 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

On-demand treatment of bleeds in haemoph

On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII

✍ B. SØRENSEN; Y. DARGAUD; G. KENET; J. LUSHER; A. MUMFORD; S. PIPE; A. TIEDE 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Single-dose (270 μg kg−1) recombinant ac

Single-dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres

✍ B. PAN-PETESCH; P. LAGUNA; A. MITAL; J. STANLEY; M. F. TORCHET; S. Z. SALEK; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB